Company Profiles

driven by the PitchBook Platform

Asterion

Description

Developer of drugs designed to help in treatment of serious chronic and acute disorders. The company's drugs are made by applying engineering techniques that has long-acting potent bio-pharmaceuticals which requires frequent administration than existing marketed drugs, enabling patients to have improved healthcare outcomes.

2001

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$530k

Latest Deal Amount

$1.19M

Total Amount Raised

3

Investors

Description

Developer of drugs designed to help in treatment of serious chronic and acute disorders. The company's drugs are made by applying engineering techniques that has long-acting potent bio-pharmaceuticals which requires frequent administration than existing marketed drugs, enabling patients to have improved healthcare outcomes.

Website:

www.asterion.co.uk

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

The Innovation Centre 217 Portobello Sheffield S1 4DPEngland +44 (0)11 4275 5555
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Asterion's full profile, request a free trial.

    Asterion Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Asterion Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    FusionIPVenture CapitalMinority000 0000000 0000
    IP GroupVenture CapitalMinority000 0000000 0000
    White Rose Technology Seedcorn FundVenture CapitalMinority000 0000000 0000
    FusionIP Venture Capital
    IP Group Venture Capital
    White Rose Technology Seedcorn Fund Venture Capital

    Asterion Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Richard RossChief Scientific Officer & Board Member
    Peter Artymiuk Ph.DFounding Scientist and Head of Molecular Design
    Richard Ross Chief Scientific Officer & Board Member
    Peter Artymiuk Ph.D Founding Scientist and Head of Molecular Design

    Asterion Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Peter Grant Ph.DIP GroupManaging Director of New Business & Partnerships000 0000
    Richard RossAsterionChief Scientific Officer & Board Member000 0000
    Peter Grant Ph.D Managing Director of New Business & Partnerships IP Group
    Richard Ross Chief Scientific Officer & Board Member Asterion
    Request full access to PitchBook